US FDA grants market authorization to six on! PLUS nicotine pouch products Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on! PLUS nicotine pouch products, through a pilot program aimed to fast-track reviews of such products. The authorization was the first under the pilot program that the FDA launched in September, and applies to six on! PLUS nicotine pouches, which are manufactured by Helix Innovations LLC, an Altria joint venture for the global on! PLUS nicotine pouch portfolio. The company had applied for premarket authorization for the products in June 2024. The decision allows the mint, tobacco and wintergreen... [Read more]